Evidence map›Paper›PMID 15024413›Full record

ArticlePLoS biology2004

A spontaneous, recurrent mutation in divalent metal transporter-1 exposes a calcium entry pathway.

Haoxing Xu, Jie Jin, Louis J DeFelice, Nancy C Andrews, David E Clapham

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Iron from the gut: the role of divalent metal transporter 1.Journal of clinical biochemistry and nutrition · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Conserved methionine dictates substrate preference in Nramp-family divalent metal transporters.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Review
  14. Article
  15. Pathophysiology of the Belgrade rat.Frontiers in pharmacology · 2014
    Review
  16. Pharmacology of iron transport.Annual review of pharmacology and toxicology · 2013
    Review
  17. Review
  18. Review
  19. Interaction of calcium with the human divalent metal-ion transporter-1.Biochemical and biophysical research communications · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Haoxing XuHoward Hughes Medical Institute, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jie Jin
Louis J DeFelice
Nancy C Andrews
David E Clapham
Howard Hughes Medical Institute · USHarvard University · USVanderbilt University Medical Center · US

Funding

Regulation of iron HomeostasisR01DK053813 · NIDDK · DUKE UNIVERSITY · PI ANDREWS, NANCY CATHERINE · 1998 to 2008
$2.5M
NIDDK NIH HHS R01 DK053813NIDDK NIH HHS R01 DK53813
6 · The paper itself

Abstract

Divalent metal transporter-1 (DMT1/DCT1/Nramp2) is the major Fe(2+) transporter mediating cellular iron uptake in mammals. Phenotypic analyses of animals with spontaneous mutations in DMT1 indicate that it functions at two distinct sites, transporting dietary iron across the apical membrane of intestinal absorptive cells, and transporting endosomal iron released from transferrin into the cytoplasm of erythroid precursors. DMT1 also acts as a proton-dependent transporter for other heavy metal ions including Mn(2+), Co(2+), and Cu(2), but not for Mg(2+) or Ca(2+). A unique mutation in DMT1, G185R, has occurred spontaneously on two occasions in microcytic (mk) mice and once in Belgrade (b) rats. This mutation severely impairs the iron transport capability of DMT1, leading to systemic iron deficiency and anemia. The repeated occurrence of the G185R mutation cannot readily be explained by hypermutability of the gene. Here we show that G185R mutant DMT1 exhibits a new, constitutive Ca(2+) permeability, suggesting a gain of function that contributes to remutation and the mk and b phenotypes.

Indexed as

MutationAlternative SplicingAnimalsBiological TransportCalciumCationsCation Transport ProteinsCell LineCHO CellsCricetinaeDNA, ComplementaryElectrophysiologyEnterocytesHumansIron-Binding ProteinsKineticsCalciumCationsCation Transport ProteinsDNA, ComplementaryIron-Binding ProteinsProtonsSolute Carrier Family 11, Member 2

Identifiers

PMID15024413
PMCPMC368157
OpenAlexW2021676916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.